Psoriasis Treatments

PSORIASIS TREATMENTS
PSORIASIS TREATMENTS

These medications are not recommended for children
and should be used for adults that are ≥18yrs old.

Generic Brand Adult Dosage
INTERLEUKIN-12 AND INTERLEUKIN-23 ANTAGONIST1
ustekinumab Stelara ≤100kg (220lbs): 45mg SC once, then 4wks later, then once every 12wks.
>100kg (220lbs): 90mg SC once, then 4wks later, then once every 12wks.
INTERLEUKIN-17A ANTAGONIST
ixekizumab Taltz 160mg (given as two 80mg SC injections) at Week 0, then 80mg at Weeks 2, 4, 6, 8, 10, and 12, then 80mg every 4wks.
secukinumab Cosentyx 300mg (given as two 150mg SC injections) at Weeks 0, 1, 2, 3, and 4 then 300mg every 4wks. For some patients, 150mg dose may be acceptable.
PSORALEN2
methoxsalen 8-MOP Take Oxsoralen-Ultra 1½–2hrs or 8-MOP 2hrs before UVA exposure with low fat food or milk. (<30kg): 10mg; (30–50kg): 20mg; (51–65kg): 30mg; (66–80kg): 40mg; (81–90kg): 50mg; (91–115kg): 60mg; (>115kg): 70mg.
Oxsoralen-Ultra
TUMOR NECROSIS FACTOR (TNF) BLOCKERS1
adalimumab Humira Initially 80mg SC, followed by 40mg every other week 1wk after initial dose.
etanercept Enbrel Initially 50mg SC twice weekly (3–4 days apart), or 25mg or 50mg per week; both for 3mos; then 50mg/week (maintenance).
infliximab Remicade 5mg/kg IV induction at Weeks 0, 2 and 6; then give every 8wks.
OTHERS
acetritin Soriatane 25–50mg orally once daily with main meal. Maintenance: 25–50mg dependent on patient response. Individualize therapy.
apremilast Otezla Starting on Day 1: 10mg in the AM. Day 2: 10mg in AM and 10mg in PM. Day 3: 10mg in AM and 20mg in PM. Day 4: 20mg in AM and 20mg in PM. Day 5: 20mg in AM and 30mg in PM. Following on Day 6 and thereafter: 30mg twice daily (AM & PM).
betamethasone dipropionate Sernivo Apply twice daily for up to max 4wks; discontinue when control is achieved.
calcipotriene + betamethasone dipropionate Enstilar Apply once daily for up to 4wks; discontinue when control is achieved; max 60g every 4 days.
cyclosporine Gengraf3 1.25mg/kg twice daily; may increase after 4wks by 0.5mg/kg/day, then adjust at 2-week intervals; max 4mg/kg/day.
Neoral3 1.25mg/kg twice daily; may increase after 4wks by 0.5mg/kg/day, then adjust at 2-week intervals; max 4mg/kg/day.
methotrexate Rasuvo 10-25mg once weekly using an oral, IM, SC, or IV form; max 30mg/wk. Use alternative MTX form in patients requiring oral, IM, IV, intra-arterial, or intrathecal dosing, doses <7.5mg/week or >30mg/week, high-dose regimens, or dose adjustments <2.5mg increments.
NOTES

1 These medications should only be used under the guidance and supervision of a physician.

2 Intended to be administered only in conjunction with a schedule of controlled doses of long wave UV radiation. See literature for UVA exposure schedule.

3 Not bioequivalent to all other forms of cyclosporine; do not interchange without physician supervision.

For more information, refer to manufacturers' full prescribing information or visit www.eMPR.com.

(Rev. 2/2017)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs